Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-04-01
著者
-
Yoshida H
National Hospital Organization Nagasaki Medical Center
-
IZUMI Namiki
Musashino Red Cross Hospital
-
KUMADA Hiromitsu
Department of Hepatology, Toranomon Hospital
-
MORIWAKI H.
Gifu University School of Medicine
-
Kumada Hiromitsu
冲中記念成人病研究所
-
Kumada Hiromitsu
Department Of Gastroenterology Toranomon Hospital
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓科
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓内科
-
Ohno Tomoyoshi
Department Of Gastroenterology Social Insurance Chukyo Hospital
-
Ohno Tomoyoshi
社会保険中京病院 消化器科
-
Nomura Hideyuki
The Center For Liver Diseases Shin-kokura Hospital
-
Iwahashi Hiromi
Department Of Internal Medicine And Molecular Science Osaka University Graduate School Of Medicine
-
Moriwaki H
First Department Of Internal Medicine Gifu University Graduate School Of Medicine
-
Moriwaki Hisataka
岐阜大学 医学部内科学
-
Moriwaki Hisataka
Dep. Of Gastroenterology Gifu Univ. School Of Medicine
-
Moriwaki Hisataka
東京大学医科学研究所
-
OSHITA Masahide
Osaka Police Hospital
-
YOSHIHARA Harumasa
Osaka Rousai Hospital
-
KUMADA Hiromitsu
Toranomon Hospital
-
Haruna Yoshimichi
大阪大学 医学系研究科消化器内科学
-
Takehara Tetsuo
大阪大学 医学系研究科消化器内科
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University
-
Takehara Tetsuo
京都府立医科大学 消化器内科学
-
Oshita Masahide
Department Of Internal Medicine Osaka Police Hospital
-
Oshita Masahide
大阪大学 医学系研究科消化器内科
-
YOSHIOKA KENTARO
Division of Gastroenterology, Department of Internal Medicine, Nagoya University School of Medicine
-
OHNO Tomoyoshi
Nagoya City University School of Medicine
-
Yoshioka K
Nagoya Univ. School Of Medicine
-
Yoshioka Kentaro
名古屋大学 医学部第3内科学
-
Yoshioka Kentaro
Department Of Hepato-biliary-pancreas Fujita Health Science
-
Okanoue T
Division Of Gastroenterology Saiseikai Suita Hospital
-
Okanoue Takeshi
愛生会山科病院 内科
-
Yamanouchi Kunio
稲沢市民病院
-
Chayama Kazuaki
Department Of Medicine And Molecular Science Graduate School Of Science Hiroshima University
-
Chayama Kazuaki
Hiroshima Univ. Hiroshima Jpn
-
OKANOUE Takeshi
Saiseikai Suita Hospital
-
Toyota Joji
Department Of Hepatology Sapporo Kosei General Hospital
-
Okanoue Takeshi
Center Of Gastroenterology And Hepatology Saiseikai Suita Hospital
-
Chayama K
Department Of Medicine And Molecular Science Graduate School Of Biomedical Sciences Hiroshima Univer
-
Chayama Kazuaki
First Department Of Internal Medicine Faculty Of Medicine Hiroshima University
-
Yotsuyanagi Hiroshi
Department Of Gastroenterology-hepatology St. Marianna Medical College
-
Chayama Kazuaki
Deparmtment Of Gastroenterology Toranomon Hospital
-
Okanoue Takeshi
Department Of Gastroenterology And Hepatology Kyoto Prefectural University Of Medicine Graduate Scho
-
Izumi Namiki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Toyama T
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Karino Yoshiyasu
Department Of Gastroenterology Sapporo Kosei General Hospital
-
Kakiuchi Yoshimi
Department Of Hepato-biliary-pancreas Fujita Health Science
-
Yoshioka Kentaro
The Third Department Of Iinternal Medicine Nagoya University School Of Medicine
-
Kumada H
Department Of Hepatology Toranomon Hospital
-
Sakisaka Shotaro
Department Of Gastroenterology And Medicine Fukuoka University School Of Medicine
-
Yoshida H
Department Of Internal Medicine Division Of Gastroenterology And Hepatology St. Marianna University
-
Yotsuyanagi Hiroshi
National Hospital Organization Nagasaki Medical Center
-
Kakiuchi Yoshimi
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Matsumoto Akinori
Third Department Of Internal Medicine Asahikawa Medical College
-
Hiasa Yoichi
Department Of Gastroenterology And Metabology Ehime University Graduate School Of Medicine
-
Toyota Jouji
Department Of Gastroenterology Sapporo Kosei General Hospital
-
Seike Masataka
Department Of Gastroenterology Oita University Faculty Of Medicine
-
Ohmura Takumi
Department Of Gastroenterology Sapporo Kosei General Hospital
-
Yoshioka Kentaro
Third Department Internal Medicine Nagoya University School Of Medicine
-
Moriwaki H
Gifu Univ. School Of Medicine Gifu Jpn
-
Moriwaki H.
First Department Of Internal Medicine Gifu University School Of Medicine
-
Katano Yoshiaki
Second Department Of Internal Medicine Nagoya University School Of Medicine
-
Moriwaki Hisataka
Department Of Gastroenterology And Hematology Division Of Organ Pathobiology Gifu University School
-
Ueno Yoshiyuki
Division Of Gastroenterology Tohoku University Graduate School Of Medicine
-
Sakisaka Shotaro
Department Of Gastroenterology And Hepatology Fukuoka University School Of Medicine
-
Yoshida Hiroshi
Department Of Infectious Disease University Of Tokyo
-
Oketani Makoto
Department Of Digestive And Life-style Related Disease Health Research Course Human And Environmenta
-
Oketani Makoto
Department Of Digestive And Lifestyle-related Disease Health Research Human And Environmental Scienc
-
Matsumoto Akihiro
Department Of Cardiothoracic Surgery The University Of Tokyo
-
Toyota Johji
Department Of Gastroenterology Sapporo Kosei General Hospital
-
Seike Masataka
Department Of Internal Medicine Faculty Of Medicine Oita University
-
Koga Hiroyuki
Department Of Hepatology Toranomon Hospital
-
Okada Toshihide
Department Of Internal Medicine Graduate School Of Medicine Kanazawa University
-
Chayama Kazuaki
First Department Of Internal Medicine Hiroshima University School Of Medicine
-
Katano Yoshiaki
Department Of Gastroenterology Nagoya University School Of Medicine
-
Nomura Hideyuki
The Center Of Liver Disease Shin-kokura Hospital
-
Yoshihara Harumasa
Department Of Internal Medicine Osaka Rosai Hospital
-
Moriwaki H.
Department Of Internal Medicine Gifu University
-
Okanoue Takeshi
Departments Of Internal Medicine And Pharmacology Kitasato University School Of Medicine
-
Oka Takahiro
Department Of Organ Transplant And Endoclinological Surgery Kyoto Prefectural University Of Medicine
-
Matsumoto Akihiro
Department Of Medicine Shinshu University School Of Medicine
-
Hayes C.
Department Of Medicine And Molecular Science Division Of Frontier Medical Science Programs For Biome
-
OKANOUE Takashi
Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital
-
Okanoue Takeshi
Third Department Of Internal Medicine Kyoto Prefectural Unicersity Of Medicine
-
Hayes C.
Department Of Medical And Molecular Science Division Of Frontier Medical Science Programs For Biomed
-
Yoshihara Harumasa
Department Of Gastroenterology And Metabology Ehime University Graduate School Of Medicine
-
Yoshida Hiroshi
Clinical Research Center National Nagasaki Medical Center
-
Moriwaki Hisataka
Department Of Medicine Gifu University Graduate School Of Medicine
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
Hiasa Yoichi
Department of Gastroenterology and Metabiology, Ehime University Graduate School of Medicine, Japan
-
NOMURA Hideyuki
The Center for Liver Disease, Shin-Kokura Hospital
-
HIASA Yoichi
Department of Gastroenterology and Hepatology, Ehime University
関連論文
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
- Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
- The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
- Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
- Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
- Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
- Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
- Systemic Sclerosis Associated with Diabetes Insipidus
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
- Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
- Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
- Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
- Involvement of GBV-C/HGV in liver diseases in Japan
- Clinical features of hepatitis B virus genotype A in Japanese patients
- Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
- Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
- Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
- Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
- Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
- Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
- Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
- Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
- Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
- Serological Study of Bartonella henselae in Cat Scratch Disease in Japan
- Relapsing Polychondritis Associated with Subclinical Sjogre's Syndrome and Phlegmon of the Neck
- Efficacy of interferon therapy for aged patients with chronic hepatitis C
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
- Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
- Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
- A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
- Protonation-Induced Conformational Changes of N,N,N',N'-Tetramethylethylenediamine. Importance of Strong N-H^+…N Hydrogen Bonding
- Conformational Order of the Alkyl Chain in a Nonionic Surfactant α-Dodecyl-ω-hydroxytris (oxyethylene) (C_E_3) in Water
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan